Results 201 to 210 of about 83,082 (294)

Impact of Wound Protectors on Complications Following Pancreaticoduodenectomy: A National Surgical Quality Improvement Program Analysis of 20 960 Patients

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background Wound protectors (WPs) have been shown to decrease postoperative wound complications, yet limited data exist supporting WP for pancreaticoduodenectomies, with limited uptake in practice. We evaluated the effect of WP in pancreaticoduodenectomies on surgical site infections (SSIs) and serious complications.
Tyrell Wees   +6 more
wiley   +1 more source

Treatment with gemcitabine/cisplatin and durvalumab for advanced biliary tract cancer - real-world data from a multicenter German patient population. [PDF]

open access: yesJ Cancer Res Clin Oncol
Gerhardt F   +13 more
europepmc   +1 more source

CARCINOMA OF THE LIVER, BILIARY TRACT AND PANCREAS

open access: hybrid, 1980
土屋 凉一   +4 more
openalex   +2 more sources

Recurrence After Gallbladder Cancer Resection: Prognostic Impact of CA19‐9 and CEA Levels at Baseline and During Surveillance

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Introduction Baseline serum carbohydrate antigen (CA) 19‐9 and carcinoembryonic antigen (CEA) levels may predict prognosis among patients undergoing resection for gallbladder cancer (GBC), yet the prognostic utility of the combination of the two markers has not been well established.
Diamantis I. Tsilimigras   +11 more
wiley   +1 more source

Sintilimab and anlotinib with gemcitabine plus cisplatin in advanced biliary tract cancer: SAGC a randomized phase 2 trial. [PDF]

open access: yesNat Commun
Li J   +19 more
europepmc   +1 more source

Two cases with unusual lung cancers metastasized from adenosquamous cancer of the biliary tract and transitional cell carcinoma of renal pelvis.

open access: bronze, 1985
Ryusei Saito   +7 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy